Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Shares Outstanding: 2020-2025

Historic Shares Outstanding for Relay Therapeutics (RLAY) over the last 6 years, with Sep 2025 value amounting to $172.6 million.

  • Relay Therapeutics' Shares Outstanding rose 3.44% to $172.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.6 million, marking a year-over-year increase of 3.44%. This contributed to the annual value of $167.8 million for FY2024, which is 31.61% up from last year.
  • Relay Therapeutics' Shares Outstanding amounted to $172.6 million in Q3 2025, which was up 0.55% from $171.7 million recorded in Q2 2025.
  • Relay Therapeutics' 5-year Shares Outstanding high stood at $172.6 million for Q3 2025, and its period low was $90.4 million during Q1 2021.
  • Over the past 3 years, Relay Therapeutics' median Shares Outstanding value was $133.3 million (recorded in 2024), while the average stood at $146.3 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first tumbled by 57.47% in 2021, then skyrocketed by 35.50% in 2024.
  • Quarterly analysis of 5 years shows Relay Therapeutics' Shares Outstanding stood at $108.2 million in 2021, then increased by 11.92% to $121.1 million in 2022, then grew by 5.24% to $127.5 million in 2023, then surged by 31.61% to $167.8 million in 2024, then rose by 3.44% to $172.6 million in 2025.
  • Its Shares Outstanding stands at $172.6 million for Q3 2025, versus $171.7 million for Q2 2025 and $170.5 million for Q1 2025.